Dr Reddys Laboratories Net Debt Growth & History (RDY)

Dr Reddys Laboratories's net debt was $365.0M for fiscal 2025.

View full Dr Reddys Laboratories company overview

Dr Reddys Laboratories annual net debt history

Dr Reddys Laboratories annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-03-31$365.0M$225.0M+160.71%
20242024-03-31$140.0M$104.0M+288.89%
20232023-03-31$36.0M−$201.0M−84.81%
20222022-03-31$237.0M$38.0M+19.10%
20212021-03-31$199.0M−$9.0M−4.33%
20202020-03-31$208.0M−$253.0M−54.88%
20192019-03-31$461.0M−$274.0M−37.28%
20182018-03-31$735.0M

Dr Reddys Laboratories net debt trends

Over the last five fiscal years, Dr Reddys Laboratories's net debt increased from $208.0M to $365.0M, a change of $157.0M. The latest reported quarter, Q4 2025, shows $365.0M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Dr Reddys Laboratories source filings ↗

Community posts

It’s quiet here.

No posts about RDY yet. Start the conversation.

Write the first post